Joseph M. Harris - Jan 5, 2023 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Christopher Melsha as attorney-in-fact for Joseph M. Harris pursuant to power of attorney previously filed.
Stock symbol
NEPH
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 03:30 PM
Previous filing
Sep 8, 2022
Next filing
Dec 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEPH Common Stock Award $0 +8.4K $0.00 8.4K Jan 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (right to buy) Award $0 +7.08K $0.00 7.08K Jan 5, 2023 Common Stock 7.08K $1.07 Direct F3
holding NEPH Stock Option (right to buy) 13.1K Jan 5, 2023 Common Stock 13.1K $1.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date.
F2 This option vests as to 4,372 shares on each of 9/6/22 and 9/6/23 and as to 4,371 shares on 9/6/24.
F3 Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.